Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality

Medicine and Dentistry

• Cardiovascular Disease 100%
• Peptide 83%
• Procollagen 83%
• Biological Marker 66%
• Mortality 66%
• Hazard Ratio 50%
• Tissue Inhibitor of Metalloproteinase 1 50%
• Gelatinase B 33%
• Extracellular Matrix 33%
• Cardiovascular System 16%
• Morbidity 16%
• Follow up 16%
• Study Participant 16%
• Age 16%
• Incidence 16%
• Woman 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Peptide 83%
• Procollagen 83%
• Biological Marker 66%
• Mortality 66%
• Death 66%
• Tissue Inhibitor of Metalloproteinase 1 50%
• Gelatinase B 33%
• Morbidity 16%
• Incidence 16%

Neuroscience

• Peptide 83%
• Procollagen 83%
• Interstitial Collagenase 50%
• Extracellular Matrix 33%
• MMP9 33%